4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework

Area of Science:

• Forensic Chemistry
• Toxicology
• Pharmacology

Background:

• Emergence of novel synthetic cannabinoids poses challenges for forensic laboratories.
• Synthetic cannabinoids contribute to drug-related morbidity and mortality.
• Accurate characterization and detection are crucial for public health and safety.

Purpose of the Study:

• To report the initial characterization of the novel synthetic cannabinoid 4F-MDMB-BINACA.
• To detail the analytical methods used for its confirmation in seized drugs and biological samples.
• To identify key metabolites of 4F-MDMB-BINACA.

Main Methods:

• Gas chromatography-mass spectrometry (GC-MS) for initial confirmation.
• Liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF) for high-resolution analysis.
• Nuclear magnetic resonance (NMR) spectroscopy for structural elucidation.
• Analysis of biological specimens from medicolegal death and impaired driving investigations.

Main Results:

• 4F-MDMB-BINACA was analytically confirmed in seized drug materials.
• The compound was detected in biological specimens from various U.S. regions.
• Metabolites 4F-MDMB-BINACA 3,3-dimethylbutanoic acid and 4-OH-MDMB-BINACA were identified.
• 4F-MDMB-BINACA is increasingly implicated as a factor in drug-related fatalities.

Conclusions:

• 4F-MDMB-BINACA is a novel synthetic cannabinoid of forensic significance.
• Comprehensive analytical methods are essential for its detection and confirmation.
• Laboratories must integrate 4F-MDMB-BINACA into their testing workflows due to its rising prevalence and association with mortality.